Why GlaxoSmithKline plc, BAE Systems plc & Imperial Brands plc are top dividend picks

GlaxoSmithKline plc (LON:GSK), BAE Systems plc (LON:BA) and Imperial Brands plc (LON:IMB) offer great dividends for the coming years.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A whole host of FTSE 100 companies have cut their dividends over the past year, reminding investors once again that even blue-chip businesses can’t guarantee their payouts.

Despite what has been touted as the world’s gradual return to economic health after the 2008/9 financial crisis, we’ve recently seen payouts slashed by companies across a range of industries: for example, Barclays in the banking sector, Rolls-Royce in aerospace, Centrica in utilities, and Rio Tinto and just about every other company in the mining sector.

It’s an unnerving situation, but I reckon investors can reduce their chances of dividend disappointment by backing GlaxoSmithKline (LSE: GSK), BAE Systems (LSE: BA) and Imperial Brands (LSE: IMB).

Improving health

The traditional defensive qualities of big pharma have been rather tested in recent years by a spate of blockbuster patent expiries, the rise of generics and a general tightening of government healthcare budgets.

Top FTSE 100 pharma group GlaxoSmithKline has suffered no less than its peers, but the days of earnings declines and talk of elevated debt being a threat to its dividend are receding.

The company reported an 8% rise in sales and core earnings for the first quarter of the current year, and gave guidance of 10-12% earnings growth for the full year. And management expects this to be just the start of a new era of strong growth.

The board intends to hold the dividend at 80p through to 2017, and I suspect a maintained dividend — or modest, inflation-matching growth — may extend a bit beyond 2017 as the company rebuilds dividend cover. However, the shares appear worth buying today at 1,450p, because the 5.5% yield on offer appears more than adequate compensation for a brighter medium- and longer-term future of growth

Solid defence

As with Glaxo, constrained government budgets in recent years haven’t been particularly helpful for defence firm BAE Systems. Nevertheless, the company has been able to deliver modest annual increases in the dividend, shielding shareholders from inflation.

And things are looking up, with the company pointing to recovering defence budgets, and growth in the group’s cyber and commercial businesses as reasons for optimism. Analysts see last year’s dividend growth of 2% accelerating to nearer 4% this year, giving a payout healthily covered 1.8 times by earnings, and a yield of 4.4% at a current share price of 490p. Again, this looks an attractive proposition.

A smokin’ 10%

At an investor day, today, Imperial Brands reaffirmed its commitment to deliver dividend growth of at least 10% a year over the medium-term. This is a continuation of the double-digit increases the company has been delivering for years, and is a testament to how well-managed and reliably cash-generative this tobacco group is.

In its half-year results announced last month, Imperial reported adjusted earnings growth of 20% and cash conversion of 105%, and the board said it is on track to meet full year expectations. As far as the dividend is concerned, the promised 10% increase gives a prospective yield of 4.1% at a current share price of 3,775p. This level of yield is not to be sniffed at, and becomes all the more attractive with the company’s commitment to double-digit annual increases over the medium-term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Barclays, Centrica, and Rio Tinto. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »